I plan to invest $50,000 from my Roth IRA account today. This is a long-term investment for me. I bought Jazz Pharmaceuticals (JAZZ) a few years ago, when the stock dropped into the $3s. Now JAZZ is in the $180s. There is a huge market for NYMX drug, and the market keeps getting bigger with the aging of the baby-boomers and generation Xs.
Sentiment: Strong Buy
Citron is just repeating the same hit piece. At least, this is an opportunity for me to finally buy AMBA on the cheap.
Hmmmm, I don't think it will get to $26 by the middle of next week. However, the acquisition they just announced adds significant value to the company. Easily over $10 by Friday of this week.
The 1st quarter numbers only covered 11 states. The 2nd quarter numbers will cover 29 states. 3rd and 4th quarter numbers will cover 41 states. With a 1st quarter 2015 non-GAAP EPS of $1.72, one can conservatively estimate the 2015 non-GAAP EPS to be about $8. Applying an average multiple of 9, (low end of 8) and (high end of 10), the share price should be about $72, by year's end. Stock should be trading close to $40 by the time 2nd quarter earnings are announced in July.